Filing Details

Accession Number:
0000850261-20-000029
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-05 13:58:44
Reporting Period:
2020-03-05
Accepted Time:
2020-03-05 13:58:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850261 Sorrento Therapeutics Inc. SRNE Biological Products, (No Disgnostic Substances) (2836) 330344842
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365035 L Robin Smith C/O Sorrento Therapeutics, Inc.
4955 Directors Place
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-05 40,000 $2.27 60,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.145 to $2.42, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.